Enobia Expands Clinical Program For ENB-0040, A Bone-Targeted Enzyme Replacement Therapy For Hypophosphatasia
Links shared publicly online about this topic.
- 1,627total visits
Enobia Expands Clinical Program For ENB-0040, A Bone-Targeted Enzyme Replacement Therapy For Hypophosphatasia
Enobia Pharma announced the initiation of a Phase 2 clinical study of ENB-0040, a bone-targeted enzyme replacement therapy, under investigation for the treatment of hypophosphatasia (HPP). The six
View full resource at medicalnewstoday.com
Tags: Pharma, Phase 2 Clinical Trial
Most Recently Shared on November 4, 2009 at 2:30 pm By:
#HEALTH Enobia Expands Clinical Program For ENB0040, A BoneTargeted Enzyme Replacement Therapy For Hypophosphatasia http://ow.ly/15ZnaD
Advertisement
